Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

CollPlant Biotechnologies (CLGN) Inventory Average (2018 - 2025)

Historic Inventory Average for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q2 2025 value amounting to $336.8 million.

  • CollPlant Biotechnologies' Inventory Average rose 435.58% to $336.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $336.8 million, marking a year-over-year increase of 435.58%. This contributed to the annual value of $577000.0 for FY2024, which is 9991.93% down from last year.
  • As of Q2 2025, CollPlant Biotechnologies' Inventory Average stood at $336.8 million, which was up 435.58% from $336.7 million recorded in Q1 2025.
  • CollPlant Biotechnologies' 5-year Inventory Average high stood at $540.5 billion for Q1 2022, and its period low was $1.0 million during Q3 2021.
  • In the last 5 years, CollPlant Biotechnologies' Inventory Average had a median value of $336.7 million in 2025 and averaged $60.4 billion.
  • Per our database at Business Quant, CollPlant Biotechnologies' Inventory Average soared by 4849703562.14% in 2021 and then crashed by 9986.76% in 2022.
  • Quarter analysis of 5 years shows CollPlant Biotechnologies' Inventory Average stood at $540.5 billion in 2021, then plummeted by 99.87% to $715.6 million in 2022, then increased by 5.07% to $751.9 million in 2023, then tumbled by 69.78% to $227.2 million in 2024, then skyrocketed by 48.22% to $336.8 million in 2025.
  • Its last three reported values are $336.8 million in Q2 2025, $336.7 million for Q1 2025, and $227.2 million during Q4 2024.